Cardiac Pathways seeks approval for heart rhythm treatment:
This article was originally published in Clinica
Cardiac Pathways has submitted an application for US approval of its cooled ablation system for treating ventricular tachycardia, a dangerously rapid heartbeat. The company is seeking expedited review for the device. The Chilli system works by burning channels in the heart with radiofrequency energy. Small tubes in the catheter deliver saline to cool the catheter tip. The system has been tested in clinical trials at 15 sites in the US involving 159 patients, most of whom had severe heart disease. Some 76% of those treated experienced complete eradication of VT after the procedure.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.